Yun Lu
14Patents
1h-index
20Co-inventors
46Inventor score
Filing activity: Sep 8, 2015 → Aug 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10786507B2 | Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereof | Human Necessities | 10 | Active |
| US10722469B2 | Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof | Human Necessities | 1 | Active |
| US11447619B2 | Thermoplastic elastomer composition | Chemistry; Metallurgy | 1 | Active |
| US12163015B2 | Thermoplastic elastomer composition | Chemistry; Metallurgy | 0 | Active |
| US10966964B2 | Method for preparing pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound | Human Necessities | 0 | Active |
| US10301344B2 | L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof | Chemistry; Metallurgy | 0 | Active |
| US10150739B2 | Crystalline form of androgen receptor inhibitor and preparation method thereof | Chemistry; Metallurgy | 0 | Active |
| US10588978B2 | Pharmaceutical composition containing imidazoline derivative | Human Necessities | 0 | Active |
| US10973807B2 | Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound | Human Necessities | 0 | Active |
| US10626116B2 | Crystalline form of BTK kinase inhibitor and preparation method thereof | Chemistry; Metallurgy | 0 | Active |
| US10258584B2 | Pregabalin sustained-release preparation | Human Necessities | 0 | Active |
| US11065241B2 | Pharmaceutical composition comprising quinoline derivative or salt thereof | Human Necessities | 0 | Active |
| US11059810B2 | Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor | Human Necessities | 0 | Active |
| US11116752B2 | Pharmaceutical composition comprising bicyclo-substituted pyrazolon azo derivative or salt thereof and preparation method thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.